Pleiotropic effects of GLP-1 treatment on renal risk factors in type 2 diabetes

被引：0
|
作者：
Petersen, E. H. [1 ]
von Scholten, B. J. [1 ]
Lindhardt, M. [1 ]
Persson, F. [1 ]
Hansen, T. W. [1 ]
Rossing, P. [1 ,2 ]
机构：
[1] Steno Diabet Ctr, Gentofte, Denmark
[2] Novo Nordisk Fdn Ctr Metab Res, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2016年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
216
引用
收藏
页码：S110 / S111
页数：2
相关论文
共 50 条
  • [21] The role of GLP-1 in the postprandial effects of acarbose in type 2 diabetes
    Dalsgaard, Niels B.
    Gasbjerg, Laerke S.
    Hansen, Laura S.
    Hansen, Nina L.
    Stensen, Signe
    Hartmann, Bolette
    Rehfeld, Jens F.
    Holst, Jens J.
    Vilsboll, Tina
    Knop, Filip K.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 184 (03) : 383 - 394
  • [22] IN TYPE 2 DIABETES MELLITUS THE GLP-1 EFFECTS ON PLATELETS ARE IMPAIRED
    Barale, C.
    Frascaroli, C.
    Cavalot, F.
    Guerrasio, A.
    Russo, I.
    ATHEROSCLEROSIS, 2016, 252 : E257 - E258
  • [23] Additive effects of GLP-1 and pioglitazone in patients with type 2 diabetes
    Zander, M
    Christiansen, A
    Madsbad, S
    Holst, JJ
    DIABETES, 2004, 53 : A342 - A342
  • [24] RESISTANCE TO THE GLP-1 EFFECTS ON PLATELETS IN TYPE 2 DIABETES MELLITUS
    Barale, C.
    Cavalot, F.
    Mattiello, L.
    Guerrasio, A.
    Russo, I
    JOURNAL OF VASCULAR RESEARCH, 2015, 52 : 50 - 50
  • [25] A novel GLP-1 analog, a dimer of GLP-1 via covalent linkage by a lysine, prolongs the action of GLP-1 in the treatment of type 2 diabetes
    Pan, Yingying
    Shi, Siwei
    Lao, Xun
    Zhang, Jinlong
    Tan, Shiming
    Wu, Zirong
    Huang, Jing
    PEPTIDES, 2017, 88 : 46 - 54
  • [26] Resistance to the GLP-1 effects on platelets in type 2 diabetes mellitus
    Barale, C.
    Cavalot, F.
    Frascaroli, C.
    Mattiello, L.
    Guerrasio, A.
    Russo, I.
    DIABETOLOGIA, 2015, 58 : S569 - S569
  • [27] GLP-1 analogues in treatment of type 1 diabetes mellitus
    Toelle, S.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (42) : 2123 - 2126
  • [28] Treatment of type 2 diabetes: New clinical studies and effects of GLP-1 on macrovascular complications
    Lesven, S.
    Gautier, J. -F.
    Marechaud, R.
    ANNALES D ENDOCRINOLOGIE, 2010, 71 (06) : 505 - 510
  • [29] Beneficial effects of Liraglutide, GLP-1 analogue, on cardiovascular risk factors in the type 2 diabetic
    Halimi, S.
    Lalanne, G.
    Ravaut, J. F.
    Reigneau, O.
    Dejager, S.
    DIABETES & METABOLISM, 2007, 33 : S18 - S18
  • [30] GLP-1 receptor agonists and cirrhosis risk in type 2 diabetes mellitus
    Pavlicek, Vojtech
    DIABETOLOGIE, 2024, 20 (08): : 897 - 898
12345